The FDA has issued a warning letter to a Chinese company it found peddling active pharmaceutical ingredients it had not manufactured or tested.

The FDA has come down on an aseptic blow-fill-seal pharma manufacturing operating in Florida that the agency says has widespread issues with microbiological…

With its $830 million deal to buy Dendreon, Chinese conglomerate Sanpower Group takes on the expensive process of manufacturing prostate cancer vaccine…

An Iranian pharma company Monday broke ground on a plant it is building as a joint venture with Azerbaijan.

In the first complete response letter of the year, the FDA has asked Boston-area biotech Tesaro for more information about manufacturing by its two contractors…

Pfizer has officially opened a plant in Saudi Arabia that it began planning more than 5 years ago.

European regulators have come down on a Danish pharma repackager that they say tried to hide violations from inspectors.

After running into time delays with its sterile drug contract manufacturer, California-based Aerie Pharmaceutical has decided to take control of future…

France’s Ipsen will get a manufacturing foothold in the U.S. with a new deal to expand its oncology reach in the country.

Manufacturing